发明名称 Agent for suppressing elevation of blood GIP concentration
摘要 An agent for suppressing elevation of blood GIP concentration and an agent for preventing or improving obesity, each of which contains a polyglutamic acid as an active ingredient.
申请公布号 US8853153(B2) 申请公布日期 2014.10.07
申请号 US201013383658 申请日期 2010.07.16
申请人 Kao Corporation 发明人 Ishimaru Kotomi;Sawada Kazuhisa;Shimotoyodome Akira
分类号 A61K38/00;A61P3/04;C08G69/10;A61K31/785 主分类号 A61K38/00
代理机构 Sterne, Kessler, Goldstein & Fox P.L.L.C. 代理人 Sterne, Kessler, Goldstein & Fox P.L.L.C.
主权项 1. A method of suppressing the rate of increase in body weight of a human subject, comprising administering to said subject 0.001 to 1.0 g of polyglutamic acid/kg body weight per day, wherein said polyglutamic acid is administered in a solid or liquid composition that either consists of polyglutamic acid or comprises a polyglutamic acid formulation, wherein the polyglutamic acid has a weight average molecular weight of 9,000 to 5,000,000; wherein the subject meets at least two of the following criteria: (1) an abdominal girth of 102 cm or more for a man and 88 cm or more for a woman; (2) a blood triglyceride level of 150 mg/dl or more or HDL cholesterol of less than 40 mg/dl, (3) a fasting blood sugar level of 110 mg/dl or more; and (4) a blood pressure of 130/85 mHg or more and suppressing the rate of increase in said subject's body weight as a result of said administering.
地址 Tokyo JP